Rheumatoid arthritis remains a debilitating condition for many retirement living seniors. According to the Center for Disease Control and Prevention, over 1.3 million adults are affected by the autoimmune disease.
Now, a new medical advancement may offer some hope to individuals who are suffering from the illness. A study in a recent online edition of the journal Science reports researchers have treated key immune cells with a new drug that keeps important enzymes at bay.
"This is an unusual mechanism that could provide a potential therapeutic approach for the treatment of autoimmune diseases like rheumatoid arthritis or inflammatory diseases like Crohns disease," says Michael Dustin, PhD, the Irene Diamond Professor of Immunology and professor of pathology at NYU Langone Medical Center.
Rheumatoid arthritis is caused by hyperactivity of the T cells that fight off diseases such as cancer.
It can eventually lead to bone deformity and joint erosion.
Retirement living seniors who are concerned about the effects of this disease should remember that advancements are being made every day toward a cure. However, seniors should make sure to visit their doctor at the first onset of symptoms, which include joint stiffness and pain.